# A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels

> **NCT04058834** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 39 (actual)

## Conditions studied

- Healthy Volunteers
- Hypercholesterolaemia

## Interventions

- **DRUG:** NNC0385-0434
- **DRUG:** Placebo (NNC0385-0434)

## Key facts

- **NCT ID:** NCT04058834
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-20
- **Primary completion:** 2020-04-23
- **Final completion:** 2020-04-23
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2021-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04058834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04058834, "A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04058834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*